Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

Clinical trial NCT00103662 · COMPLETED

Trial details

NCT number: NCT00103662
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2005-01-01
Primary completion: 2006-10-01
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.